Teleflex Incorporated (NYSE: TFX) announced it has nominated Michael J. Tokich, a medical technology industry veteran, for election to its board of directors at the 2026 annual meeting. The company also said it plans to begin share repurchases in the second quarter, ahead of its previously announced schedule.

Tokich brings more than 30 years of experience in public company finance and medical technology. He previously served as senior vice president and chief financial officer at STERIS plc for 18 years, where he helped grow the company's market capitalization from $1 billion to over $22 billion. He currently serves on the board of directors of Mettler-Toledo International Inc.

The Wayne, Pennsylvania-based medical device company said Andrew A. Krakauer will become chairman of the board following the annual meeting, succeeding Dr. Stephen Klasko, who is stepping down to pursue a new healthcare leadership role. John Heinmiller will also conclude his board term at the annual meeting.

Teleflex plans to establish a Growth and Operating Committee to support management during what it describes as a significant transformation period. The committee will focus on operational execution and identifying growth opportunities.

The company said it will commence opportunistic share repurchases under its existing $1 billion authorization during the second quarter, earlier than previously planned. Teleflex had initially expected to begin share purchases after completing planned sales of its OEM, Acute Care and Interventional Urology businesses, which remain scheduled to close in the second half of 2026.

The share repurchases will be subject to market conditions and the company's operating cash flow needs, according to the statement.